CPF Texas’s GSK GSK Stock Holding History

CPF Texas’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-400	Closed	-$18K	–	253
2017 Q4	$18K	Buy	+400	New	+$18.5K	0.01%	214

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CPF Texas's GSK Position: Q1 2018 in Review

CPF Texas sold out of GSK (GSK) in Q1 2018, closing a stake of 400 shares — an estimated $18K sold.

CPF Texas first reported a position in GSK in Q4 2017 and held it in 1 quarter. The position peaked at $18K in Q4 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

CPF Texas reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
CPF Texas sold 400 GSK shares in Q1 2018, an estimated $18K.
CPF Texas first reported a position in GSK in Q4 2017 and held it in 1 quarter.
CPF Texas's GSK position peaked at $18K in Q4 2017.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on CPF Texas's 13F filing for Q1 2018, filed 24 May 2018.